Vigil Neuroscience, Inc. (VIGL)

NASDAQ: VIGL · IEX Real-Time Price · USD
13.50 -0.10 (-0.74%)
Jan 25, 2022 9:46 AM EST - Market open
Market Cap381.56M
Revenue (ttm)n/a
Net Income (ttm)-34.53M
Shares Out28.26M
EPS (ttm)-1.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,308
Open13.05
Previous Close13.60
Day's Range13.05 - 13.99
52-Week Range10.52 - 14.55
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About VIGL

Vigil Neuroscience is a microglia-focused company dedicated to improving the lives of patients, caregivers and families affected by rare and common neurodegenerative diseases. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system health and responding to damage caused by disease. Leveraging recent research implicating microglial dysfunction in neurodegenerative diseases, we utilize a precision medicine approach to develop a pipeline of therapeutic candidates, initially addressing gen...

IndustryBiotechnology
IPO DateJan 7, 2022
CEOIvana Magovčević-Liebisch
Employees30
Stock ExchangeNASDAQ
Ticker SymbolVIGL
Full Company Profile

News

Vigil Neuroscience Announces Closing of Initial Public Offering

CAMBRIDGE, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ne...

1 week ago - GlobeNewsWire

Vigil Neuroscience Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ne...

2 weeks ago - GlobeNewsWire